Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lucia Dominguez

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Vaccine|November 26, 2009
Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responsesAna Lucia Dominguez, Joseph Lustgarten
Cancer Research|July 3, 2008
Implications of aging and self-tolerance on the generation of immune and antitumor immune responsesAna Lucia Dominguez, Joseph Lustgarten
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
High accumulation of T regulatory cells prevents the activation of immune responses in aged animalsSanjay Sharma, Ana Lucia Dominguez, Joseph Lustgarten
European Journal of Immunology|March 3, 2004
The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activityJoseph Lustgarten, Ana Lucia Dominguez, Camilo Cuadros
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Aged mice develop protective antitumor immune responses with appropriate costimulationJoseph Lustgarten, Ana Lucia Dominguez, Marilyn Thoman
Experimental Gerontology|November 18, 2005
Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BBSanjay Sharma, Ana Lucia Dominguez, Joseph Lustgarten
Cancer Immunology, Immunotherapy : CII|September 11, 2007
CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the agedSanjay Sharma, Ana Lucia Dominguez, Dominique B Hoelzinger, et al.
Cancer Research|October 3, 2003
Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu miceCamilo Cuadros, Ana Lucia Dominguez, Gregory I Frost, et al.
Aging Cell|June 30, 2011
Comparative kinetic analyses of gene profiles of naïve CD4+ and CD8+ T cells from young and old animals reveal novel age-related alterationsNoweeda Mirza, Kevin Pollock, Dominique B Hoelzinger, et al.
Cancer Research|October 10, 2014
Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challengesDominique B Hoelzinger, Ana Lucia Dominguez, Peter A Cohen, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Vaccine|November 26, 2009
Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responsesAna Lucia Dominguez, Joseph Lustgarten
Cancer Research|July 3, 2008
Implications of aging and self-tolerance on the generation of immune and antitumor immune responsesAna Lucia Dominguez, Joseph Lustgarten
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
High accumulation of T regulatory cells prevents the activation of immune responses in aged animalsSanjay Sharma, Ana Lucia Dominguez, Joseph Lustgarten
European Journal of Immunology|March 3, 2004
The CD8+ T cell repertoire against Her-2/neu antigens in neu transgenic mice is of low avidity with antitumor activityJoseph Lustgarten, Ana Lucia Dominguez, Camilo Cuadros
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2004
Aged mice develop protective antitumor immune responses with appropriate costimulationJoseph Lustgarten, Ana Lucia Dominguez, Marilyn Thoman
Experimental Gerontology|November 18, 2005
Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BBSanjay Sharma, Ana Lucia Dominguez, Joseph Lustgarten
Cancer Immunology, Immunotherapy : CII|September 11, 2007
CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the agedSanjay Sharma, Ana Lucia Dominguez, Dominique B Hoelzinger, et al.
Cancer Research|October 3, 2003
Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu miceCamilo Cuadros, Ana Lucia Dominguez, Gregory I Frost, et al.
Aging Cell|June 30, 2011
Comparative kinetic analyses of gene profiles of naïve CD4+ and CD8+ T cells from young and old animals reveal novel age-related alterationsNoweeda Mirza, Kevin Pollock, Dominique B Hoelzinger, et al.
Cancer Research|October 10, 2014
Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challengesDominique B Hoelzinger, Ana Lucia Dominguez, Peter A Cohen, et al.
Pageof 2